Wolverine Drug — Protocol

BPC-157 Protocol & Dosage

Evidence-informed dosing guidance for BPC-157, including oral vs. injectable methods, stacking with TB-500, and optimized cycling protocols.

Access on Fullscript

1 Standard Dosage Ranges

Route Dose Range Frequency Best For
Oral Capsule 250–500 mcg Once daily GI healing, gut health
Sublingual 250–500 mcg Once daily Systemic use, moderate bioavailability
Subcutaneous 250–500 mcg Once daily Systemic healing, injuries remote from gut
Intramuscular 250–500 mcg Once daily Localized injury near injection site

* Doses derived from animal model extrapolations. No established human clinical dosing exists.

2 Oral vs. Injectable — Choosing Your Method

Oral / Capsule

Oral BPC-157 acts locally within the GI tract before being absorbed systemically. The lower systemic bioavailability is actually an advantage for gut-targeted use. Oral forms are also the most practical for daily use.

  • + No needles, simple dosing
  • + Ideal for IBD, leaky gut, ulcers
  • + Some systemic absorption still occurs
  • – Lower systemic bioavailability

Injectable (SC / IM)

Injectable BPC-157 delivers full systemic availability. For musculoskeletal injuries, subcutaneous injection near the injury site is commonly reported in anecdotal use. Intramuscular is used for direct localized delivery.

  • + Maximum systemic bioavailability
  • + Better for tendon, ligament, bone
  • + Precise localized dosing possible
  • – Requires sterile technique

3 BPC-157 + TB-500 Stack

TB-500 (Thymosin Beta-4) is another research peptide commonly stacked with BPC-157. While BPC-157 drives local tissue regeneration and angiogenesis, TB-500 promotes systemic cell migration and actin upregulation for broader healing. Together they are considered by many researchers to offer complementary and synergistic effects.

Sample Stack Protocol

BPC-157 250 mcg Daily SC or Oral
TB-500 2–2.5 mg 2× per week Subcutaneous

These products are available pre-formulated on Fullscript.

COMBO

Quicksilver BPC + TB-500 Combo

Injury Stack

The gold-standard injury recovery stack — BPC-157 paired with TB-500. Pre-formulated for convenience, ideal for the stack protocol above.

Access on Fullscript

Infiniwell BPC-157 Rapid Pro

Rapid Release

Fast-release oral capsules for quick systemic absorption. A strong standalone option for musculoskeletal recovery protocols.

Access on Fullscript

See all formulations on the buy page.

4 Cycling Strategy

Short-term

Acute Injury Protocol

Run for 4–6 weeks at 500 mcg/day until the injury resolves. Discontinue and reassess.

Medium-term

Chronic Condition Protocol

8–12 week cycle with 4–6 weeks off. Monitor for ongoing improvement before re-running.

GI-specific

Gut Healing Protocol

Oral 250–500 mcg for 8–12 weeks. Can be extended with practitioner supervision given strong GI safety profile.

Disclaimer

This protocol information is derived from animal research and community anecdotal reports. BPC-157 is not approved for human use by the FDA or any other regulatory body. Always consult a licensed healthcare practitioner before starting any peptide protocol.

Get Started with BPC-157

Access professional-grade BPC-157 and BPC-157 + TB-500 combinations through Fullscript.

Access on Fullscript